Navigation Links
'Superbugs' on the rise in Canadian hospitals, new Queen's study shows
Date:11/7/2008

Kingston, ON Although infection control has been substantially ramped up in Canadian hospitals since the SARS crisis of 2003, the number of resistant bacterial infections post-SARS have multiplied even faster, a new Queen's University study shows.

Led by Queen's epidemiologist Dr. Dick Zoutman, the national survey is a six-year follow-up to a study that was undertaken in 1999, prior to the outbreak of SARS (Severe Acute Respiratory Syndrome).

The original, groundbreaking study, funded by the Public Health Agency of Canada, showed that most Canadian hospitals fell seriously short in preventing patients from getting hospital infections. The researchers estimated then that about 250,000 patients a year experience infected surgical wounds, blood infections, and antibiotic-resistant organisms while in hospital and that 8,000 of these patients will die.

Findings from the new Queen's study which draws on data from 2005 will be published in the December issue of the American Journal of Infection Control.

While human resources to combat the problem have increased significantly particularly in Ontario and Quebec the number of hospital-acquired infections has risen even faster. "The combination of more infection control practitioners and activity, but also more bugs, hasn't taken us where we want to be," says Dr. Zoutman, who is director of Infection Prevention and Control at Kingston General Hospital. "We've made some strides, but there is still a lot to do. We'd like to see increased surveillance and control activities, which our study indicates haven't been achieved yet."

Since the first survey was conducted, the rates of MRSA (Methicillin-resistant Staphylococcus aureus) have more than doubled across Canada, from 2.0 to 5.2 per 1,000 hospital admissions. Another deadly bacterium, VRE (Vancomycin-resistant enterococcus), was found in 77 per cent more hospitals in the 2005 survey than in 199
'/>"/>

Contact: Nancy Dorrance
nancy.dorrance@queensu.ca
613-533-2869
Queen's University
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Key Cleaning Solutions Products Utilized to Combat Community Acquired - MRSA (CA-MRSA) Are Succeeding In Killing Superbugs Where Normal Cleaning Practices and Products Are Not
2. Six Simple Steps to Protect Against and Stop the Spread of Superbugs
3. Scientists strike blow in superbugs struggle
4. Green Tea Boosts Antibiotics for Superbugs
5. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
6. Ibuprofen can slow lung disease in children with cystic fibrosis, Canadian study shows
7. New Canadian study finds drug coated heart stents to be safe:
8. Canadians welcome HPV vaccine -- but not at any price
9. Mayo Clinic Calls for Thorough Review of Canadian Pacifics Acquisition of the Dakota, Minnesota & Eastern Railroad
10. Canadian Pacific and Mayo Clinic Build Understanding and Commit to Ongoing Dialogue
11. Map the Canadian Healthcare IT Market with the New HIMSS Analytics Canadian Database(SM)

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Superbugs' on the rise in Canadian hospitals, new Queen's study shows
'Superbugs' on the rise in Canadian hospitals, new Queen's study shows
(Date:11/21/2009)...USNewswire/ -- A regional initiative launched in t...ess) in the Americas has substantially reduced the...denced by a 31% decrease in the number of individu...mic countries. Results were reported today at the...opical Medicine and Hygiene (ASTMH). ,, The re...
(Date:11/21/2009)...edentialing software company IntelliSoft Group is ...th Amerinet, Inc., the leading healthcare G.P.O. i...m quality care within the healthcare market. , ... ISG Group, LLC, doing business as IntelliSoft Gro...c., a leading national healthcare group purchasing...
(Date:11/21/2009)...dent and chief executive officer of the Alzheimer,... statement regarding the inclusion of cognitive im...ess for Medicare beneficiaries in "The Patien...s introduced last night: , .... Hall, president and chief executive officer of t...
(Date:11/20/2009)...nderstanding Brain Wiring and Diseases ,, WASHI...my Schmahmann, Professor of Neurology at Harvard M... General Hospital in Boston, on Thursday, November...w field of study called "Connectivity" at the laun...n is an award-winning leader in the field of the c...
(Date:11/20/2009)...re-USNewswire/ -- The United States Conference of ...l changes its health reform bill in order to keep ...ience protection on abortion, protect access to he...ions for adequate affordability. ,, The bishops...isappointment" that creates new and unacceptable f...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2
...dietary habits and increased weight in the middle ... of high calorie diet and employment of food as mo...the students//. Other factors such as selling food...hildren population are burdened with this curse of...
...HIV positive people of Mizo society to treat them ...eath. Malsawmdawnga who is the president of Mizora... press talk stating that even as the world is chan...ad bodies of AIDS patients in polytene bags before...
...ai spoke to the press about improvising the health...aid that the city needs more hospitals with ICUs//...ices, which are easily accessible by the public. ...inister Mr. Nitish Kumar is also having a keen int...
...ed for curtailing comparative advertisements, afte...ucers//. Suitable amendments should be made to the...n addition to other media and channels, and the Mo...roducts of a competitor are concerned. Comparative...
...pal gas leak tragedy was on Saturday 30 doctors of...resigned. The doctors wanted a pay hike. The...treatment daily. Run by a trust, the BMHRC was set...aintenance Act (ESMA) has been imposed on the juni...
...st bird flu to all its poultry birds and wild bird...ess program to farmers and villagers about the imp... the villagers to report immediately any doubtful ...lu and is an increased threat for mutation of the ...
Other Medicine News:Health News:Conditions Of The HIV/AIDS Patients In The Mizo Society 2
(Date:11/20/2009)..., , FRANKLIN LAKES, N.J., Nov. 20 /PRNewswi...) (NYSE: BDX ) today announced the completion of...Michigan-based company that develops and manufactu...tforms. ,, In May 2009, BD and HandyLab announc...mmercialize molecular assays on the HandyLab Jagua...
(Date:11/20/2009)..., , PRINCETON, N.J., Nov. 20 /PRNewswire-... SNGX) (Soligenix or the Company), formerly known ... company, announced today that it has formed a con...nce RiVax(TM) and other rapidly acting vaccines. S...tional Institute of Allergy and Infectious Disease...
(Date:11/19/2009)..., , BIRMINGHAM, Ala., Nov. 19 /PRNewswire...daq: BCRX ) today announced the pricing of a publ...k at $9.75 per share, resulting in gross proceeds ...fered by BioCryst pursuant to an effective shelf r...curities and Exchange Commission. BioCryst has al...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3WuXi PharmaTech Announces Second Quarter 2009 Results 13509 1WuXi PharmaTech Announces Second Quarter 2009 Results 13509 2WuXi PharmaTech Announces Second Quarter 2009 Results 13509 3WuXi PharmaTech Announces Second Quarter 2009 Results 13509 4WuXi PharmaTech Announces Second Quarter 2009 Results 13509 5WuXi PharmaTech Announces Second Quarter 2009 Results 13509 6WuXi PharmaTech Announces Second Quarter 2009 Results 13509 7WuXi PharmaTech Announces Second Quarter 2009 Results 13509 8WuXi PharmaTech Announces Second Quarter 2009 Results 13509 9WuXi PharmaTech Announces Second Quarter 2009 Results 13509 10WuXi PharmaTech Announces Second Quarter 2009 Results 13509 11WuXi PharmaTech Announces Second Quarter 2009 Results 13509 12WuXi PharmaTech Announces Second Quarter 2009 Results 13509 13WuXi PharmaTech Announces Second Quarter 2009 Results 13509 14WuXi PharmaTech Announces Second Quarter 2009 Results 13509 15WuXi PharmaTech Announces Second Quarter 2009 Results 13509 16VIVUS Reports Second Quarter 2009 Financial Results 54258 1VIVUS Reports Second Quarter 2009 Financial Results 54258 2VIVUS Reports Second Quarter 2009 Financial Results 54258 3VIVUS Reports Second Quarter 2009 Financial Results 54258 4VIVUS Reports Second Quarter 2009 Financial Results 54258 5VIVUS Reports Second Quarter 2009 Financial Results 54258 6VIVUS Reports Second Quarter 2009 Financial Results 54258 7Mesa Labs Reports Higher First Quarter Earnings 54256 1Mesa Labs Reports Higher First Quarter Earnings 54256 2Mesa Labs Reports Higher First Quarter Earnings 54256 3Mesa Labs Reports Higher First Quarter Earnings 54256 4Mesa Labs Reports Higher First Quarter Earnings 54256 5
...ebruary 26 ExonHit Therapeutics,(Alternext: ALEHT...EHT 0202,its lead compound in Alzheimer,s disease,...ase IIa trial assessing EHT 0202 in patients with,...ssful completion of patient enrolment for the Phas...elopment of EHT 0202, and,provides a clear timelin...
...cians at Northwestern Memorial are among the first...al natural orifice translumenal endoscopic surgery...thwestern Memorial Hospital successfully removed a...them the first in the Midwest and the third in the...technique, known as NOTES -- natural orifice trans...
Other Medicine Technology:ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 4Gallbladder Removal Through Vagina Offers Minimally Invasive Alternative 2Gallbladder Removal Through Vagina Offers Minimally Invasive Alternative 3
RT-600
...ractor. The RT-300's accessory knob is positioned ...ols are within a hand's breadth of each other. Cyl...5 to -19.00D. "Sure-grip" knurls on the control kn...venient placement of the controls themselves, this...
Ultramatic RX Master PHOROPTOR Refracting Instrument - Plus Cylinder Black
Double Maddox
Medicine Products: